Amarna Therapeutics

Pharmaceutical Manufacturing • Leiden, South Holland, Netherlands • 11-20 Employees

Company overview

Headquarters	J.H. Oortweg 21, Leiden, 2333CH, NL
Website	amarnatherapeutics.com
NAICS	3254
SIC	873
Founded	2008
Employees	11-20
Socials

Key Contacts at Amarna Therapeutics

Ben Van Leent

Founder Amarna Therapeutics

Thijs Gerritzen

Director Cmc Development

Peter De Haan

Cso And Co-Founder

Amarna Therapeutics Email Formats

Amarna Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@amarnatherapeutics.com), used 72.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@amarnatherapeutics.com	72.7%
{first initial}.{last name}	j.doe@amarnatherapeutics.com	27.3%

About Amarna Therapeutics

Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of both rare and prevalent diseases. The company is pioneering the development of gene therapies based on simian virus 40 (SV40), a macaque polyoma virus to which humans are immunologically naïve. Amarna has created a proprietary production cell line (SuperVero™) that, for the first time, makes it possible to produce SV40-derived vectors suitable for therapeutic use. Combining SuperVero™ with its genetically engineered SVec viral vector, the company’s fully-integrated gene therapy platform is truly unique in its intrinsic capability to deliver transgenes without eliciting immune responses to the vector nor to the transgene product. Leveraging this ‘natural’ non-immunogenicity feature of its gene delivery system in humans, Amarna is developing a broad pipeline of safe, effective and durable gene therapies focused on genetic disorders, autoimmune diseases and chronic inflammation. Founded in 2008, Amarna’s head office is based in Leiden Bio Science Park, the Netherlands, with a research subsidiary located in Seville, Spain.

Amarna Therapeutics revenue & valuation

Annual revenue	$1,454,435
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$4,700,000
Total funding	No funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

C-Suite

Entry

Employees by Department

Amarna Therapeutics has 7 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Amarna Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-02-11	9	N/A

Funding Insights

Number of funding rounds

Amarna Therapeutics Tech Stack

Discover the technologies and tools that power Amarna Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

reCAPTCHA

Security

Cookie Control

Cookie compliance

Google Maps

Maps

Microsoft 365

jQuery

JavaScript libraries

PHP

Programming languages

Google Analytics

Analytics

Bootstrap

UI frameworks

Google Tag Manager

Tag managers

Nginx

Reverse proxies

GSAP

JavaScript frameworks

Frequently asked questions

Amarna Therapeutics is located in Leiden, South Holland, NL.

Amarna Therapeutics was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

Amarna Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.